yes agree, however AGY are further along now, although not as far as we would like to see but further none the less.
2ktpa plant running continuously does shift negotiation power into AGYs territory, especially when demand picks back up or supply slows due to low pricing.
- Forums
- ASX - By Stock
- AGY
- Li-related News/Articles/Reports
Li-related News/Articles/Reports, page-8934
Featured News
Add AGY (ASX) to my watchlist
|
|||||
Last
8.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $123.7M |
Open | High | Low | Value | Volume |
8.5¢ | 8.5¢ | 8.5¢ | $10.77K | 126.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 250479 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 113611 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 353529 | 0.085 |
4 | 219873 | 0.084 |
2 | 19062 | 0.083 |
2 | 136585 | 0.082 |
2 | 114691 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 109366 | 1 |
0.087 | 193664 | 2 |
0.088 | 232558 | 1 |
0.089 | 69615 | 2 |
0.090 | 91167 | 2 |
Last trade - 10.02am 16/07/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online